Corporate | 27 February 2008 16:51
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Miscellaneous
Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Berlin, 27 February 2008. The Eckert & Ziegler AG (ISIN DE 0005659700,
based in Berlin), a specialist in tumor radiation systems und implants for
cancer treatment has acquired a large order thus strengthening its market
position as a supplier for radiation therapy products in Spain. The
newly-founded Eckert & Ziegler Iberia S.L. based in Madrid succeeded in
winning a tender for the long-term supply of various regional hospitals
amounting to 0.7 million EUR.
'Spain is one of the largest European markets for brachytherapy products',
explains Dr. Edgar Löffler, Executive Board member of the Eckert & Ziegler
AG and Managing Director of Eckert & Ziegler Iberia S.L. 'We are glad to
increase our product presence in Spain and made the right decision to serve
the market more effectively by setting up a wholly-owned subsidiary.'
The implants for the treatment of prostate cancer are millimeter-sized,
weakly radioactive sources which are implanted in the prostate by means of
a hollow needle. In contrast to the surgical removal of the prostate, this
treatment –being equally effective - causes considerably less incontinence
and impotence rates. Prostate cancer is the most frequent cancer for men
in Europe with 135,000 new incidences annually.
In combination with special eye applicators, these sources are used to
treat eye cancer.
Apart from its German and Spanish locations, Eckert & Ziegler maintains
offices in Los Angeles, Atlanta, San Francisco, Prague, Paris, Milan und
Chennai (India) and employs more than 350 people.
The Executive Board
Your contact:
Eckert & Ziegler AG
Thomas Scheuch, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-139, Fax –112, E-mail: thomas.scheuch@ezag.de,
www.ezag.de
27.02.2008 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------